Your Ovaries Aren't Done, Your Heart Is at Risk, and That Weird Symptom Has a Name
Quick Summary
Today's episode covers three things that don't get enough airtime: a common menopause symptom that can genuinely frighten the women experiencing it, new science showing post-menopause ovaries are still doing something (researchers just don't know what yet), and a cardiologist's breakdown of why the heart disease window opens during perimenopause and what that actually means for your health.
Your Ovaries Aren't Done, Your Heart Is at Risk, and That Weird Symptom Has a Name
Key Takeaways
- ✦Palpitations — a fluttery, racing, or skipping heartbeat — are a recognized menopause symptom affecting a significant portion of women, often dismissed or misattributed to anxiety.
- ✦Post-menopause ovaries are not simply "off." Research shows they continue producing hormones and other signals, though scientists are still working out what role that activity plays.
- ✦Heart disease kills more women than breast cancer, and the hormonal shifts of perimenopause — particularly the drop in estrogen — directly affect how the heart and blood vessels function.
- ✦80–90% of heart disease comes down to blockages in the coronary arteries, and the risk trajectory for women can begin shifting years before the final menstrual period.
- ✦The perimenopause window may be a critical time for cardiovascular prevention — not something to address only after symptoms appear.
Sources & References
Episode Script
Thanks Toni. We've got a good one today.
Three things on the table: a symptom that scares a lot of women and gets dismissed almost as often, some genuinely surprising new science about what your ovaries are doing after menopause, and a cardiologist making the case that the heart disease conversation needs to start during perimenopause — not after.
So. Heart palpitations.
If you've felt your heart flutter, race, skip a beat, or suddenly pound for no obvious reason — and you've also been in perimenopause or post-menopause — there's a good chance those two things are connected. A Star Tribune piece this week covered this, and the reason it's worth a full segment is that palpitations are one of those symptoms that gets taken seriously in the wrong direction. Meaning: women do get taken seriously when they report them, but they tend to get routed toward anxiety diagnoses or cardiac workups that come back clean, and the menopause connection gets skipped entirely.
Palpitations are a real, recognized menopause symptom. Studies have found them in somewhere between 25 and 40 percent of perimenopausal and menopausal women, depending on how you define the symptom and how you measure it. That's not a small number. And the mechanism makes sense when you think about what estrogen actually does in the body — it's not just a reproductive hormone. It has direct effects on the heart and the electrical system that keeps your heartbeat regular. When estrogen levels start swinging around in perimenopause, that electrical system can get a little unsteady.
Most menopause-related palpitations are benign. They're uncomfortable and they can be genuinely alarming, but they're not usually a sign that something dangerous is happening. That said — and this matters — palpitations can also be a symptom of something that does need medical attention. Thyroid issues, anemia, actual arrhythmias. So the right move isn't to assume it's menopause and move on. It's to get it checked out, have menopause specifically on the table as a possible explanation, and not let "your anxiety is acting up" be the end of the conversation if something feels off.
The piece made the point that women who experience these often feel like they're being dramatic, or they convince themselves they're having a heart attack, and neither response is especially useful. Knowing that this is a thing — a documented, common, hormonally-driven thing — is genuinely clarifying. It doesn't replace a conversation with your doctor, but it means you walk into that conversation with better information.
The WIRED piece this week was about something I find genuinely fascinating from a pure biology standpoint: the post-menopause ovary.
The standard story most of us have been told is that menopause means the ovaries essentially retire. They stop releasing eggs, estrogen drops, and they become, more or less, inactive. Turns out that's not quite right.
Researchers are finding that after menopause, ovaries don't go quiet. They keep producing hormones — including small amounts of testosterone and other androgens — and they're doing things at the cellular level that scientists are still trying to map out. One researcher quoted in the piece described it as "surprisingly active tissue." There are cells in the post-menopause ovary that are still turning over, still responding to signals from the brain, still secreting things. The question of what that activity is for — whether it's protective, whether it's vestigial, whether it has implications for health outcomes — is very much open.
This is early science. It would be a mistake to read too much into it right now. No one is saying post-menopausal ovarian activity is a treatment target yet, or that it explains specific symptoms. What they're saying is that the picture is more complicated than we thought, and that we probably have a lot to learn about what ovaries are actually doing in the second half of a woman's life.
My read on this: the fact that we're only now asking these questions in depth says something uncomfortable about how little research attention women's post-reproductive biology has historically received. The ovary gets studied intensively up until it stops making eggs, and then interest drops off. If this were a gland with as much relevance to men's health, we'd have known this twenty years ago. The science is moving now — but it's worth acknowledging the gap.
The unPAUSED podcast this week featured Dr. Jeremy London, a cardiovascular surgeon with over 25 years of experience and thousands of surgeries behind him, talking with Dr. Mary Claire Haver about heart disease and menopause. This is a conversation that deserves more airtime, so I want to spend some real time on it.
Heart disease is the number one killer of women. Not breast cancer. Heart disease. That's not a rhetorical point — it's a fact that consistently surprises people, and the surprise itself is part of the problem. The cultural narrative around women's health has centered so heavily on breast cancer that cardiovascular risk has been chronically underestimated, underdiscussed, and underfunded when it comes to women specifically.
Dr. London's breakdown: about 80 to 90 percent of heart disease comes down to blockages in the coronary arteries — the vessels that supply blood to the heart muscle itself. Those blockages build up over time, driven by a combination of things: blood pressure, blood sugar, inflammation, cholesterol, smoking, inactivity. Standard risk factors. But here's where menopause enters the picture directly.
Estrogen is protective for blood vessels. It helps keep them flexible. It has anti-inflammatory effects. It supports a healthier cholesterol balance — specifically, it tends to keep HDL (the kind you want more of) higher and LDL (the kind you want less of) lower. When estrogen drops during perimenopause and menopause, those protective effects go with it. Blood vessels can stiffen. Cholesterol numbers can shift in the wrong direction. Inflammation markers can rise. And all of that starts happening during the perimenopause years — which for most women begins in the mid-to-late forties.
The window that Dr. London and Dr. Haver were focused on is perimenopause specifically. Not post-menopause — perimenopause. The years when hormones are fluctuating wildly but periods haven't stopped yet. That's when the cardiovascular trajectory can start to shift, and that's exactly when most women — and many doctors — are not thinking about heart disease prevention. They're thinking about irregular cycles and hot flashes. The connection to long-term heart health is not on the radar.
Dr. London made a point that stuck with me: cardiovascular disease is a process that takes decades to develop. The choices and the biology of your forties are setting the stage for what your arteries look like in your sixties and seventies. That's not meant to be terrifying — it's meant to be useful. Because the perimenopause window is also a window for intervention. Strength training, protein intake, sleep, blood pressure management, getting your cholesterol actually looked at and taken seriously — these things matter more during this window than they might have in your thirties, and they matter differently.
The piece also touched on something that frustrates me: that women in perimenopause often don't get cardiovascular risk assessed with any seriousness because the symptom picture looks like menopause symptoms. Fatigue, sleep disruption, palpitations, shortness of breath on exertion — all of these can be menopause. All of these can also be early cardiac symptoms. Getting them sorted requires a doctor who knows to ask both questions, not just one.
If you take one thing from this segment, it's that "my cholesterol and blood pressure" is not a conversation to defer until your mid-fifties. The perimenopause years are when it gets relevant, and getting ahead of that curve is genuinely possible.
Sources curated automatically by the Hot Flasher pipeline.
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.